{"public_id":"cl_199eed958e5ea91fdc71872d9c05b2dc","status":"active","superseded_by_public_id":null,"corpus_id":9330608,"text":"An siRNA-based therapeutic strategy targeting antiapoptotic genes can be designed to overcome chondrosarcoma chemoresistance.","confidence":0.9,"paper":{"corpus_id":9330608,"title":"siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells","url":"https://sah.borca.ai/papers/9330608"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_52b56d20507f511b2bb069e63fde692f","name":"siRNA-based therapeutic strategy","description":"A treatment strategy that uses siRNA to suppress disease-related gene expression.","types":["therapeutic strategy"],"url":"https://sah.borca.ai/concepts/co_52b56d20507f511b2bb069e63fde692f"},{"public_id":"co_6663b056ce20813244c31660b0b4d81f","name":"antiapoptotic genes","description":"Genes encoding proteins that suppress apoptosis and support cell survival.","types":["gene set"],"url":"https://sah.borca.ai/concepts/co_6663b056ce20813244c31660b0b4d81f"},{"public_id":"co_fd52b8dc85c84cc880db4aa89a514620","name":"chondrosarcoma chemoresistance","description":"Drug resistance specifically associated with chondrosarcoma cells.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_fd52b8dc85c84cc880db4aa89a514620"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_199eed958e5ea91fdc71872d9c05b2dc"}